Top 75 MGAs 2023: £30m - £40m

MGA 30-40

AutoProtect, Avantia, CFC Group, EGV (Holdings), Howden Group Holdings, and PIB Group achieved MGA/MGU revenues between £30m and £40 from UK-based non-life risks in 2022.

AutoProtect provides insurance products and dealer warranties to vehicle manufacturers and retailers of all types throughout the UK, Europe and globally.

Avantia is the investment company behind Homeprotect, a direct-to-consumer brand for home insurance.

Most of CFC Group’s revenues are derived from international non-life risks, according to Insuramore, which produced Insurance Post’s Top 75 MGAs list.

EGV (Holdings)’s main MGA-MGU activities dealing in UK-based non-life risks in 2022 were Artsure, Broker Express and Eaton Gate Commercial.

Howden Group Holdings’s main MGA-MGU activities dealing in UK-based non-life risks in 2022 were Dual and KGM Underwriting Services. A majority of Dual’s revenues, not considered for this list by Insuramore, are derived from international non-life risks.

PIB Group’s main MGA-MGU activities dealing in UK-based non-life risks in 2022 were Citynet Underwriting Services, Let Alliance, Q Underwriting, Thistle Insurance Services and UK Insurance Net.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Big Interview: Nadia Côté and Serge Raffard, Allianz

After being named managing directors of Allianz Commercial and Allianz Personal, respectively, Nadia Côté and Serge Raffard met with Scott McGee to discuss their respective markets, how they have settled in, and where they see their businesses growing in 2024.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here